WO2010019279A8 - Compositions pharmaceutiques configurées pour dissuader le fractionnement des formes posologiques - Google Patents
Compositions pharmaceutiques configurées pour dissuader le fractionnement des formes posologiques Download PDFInfo
- Publication number
- WO2010019279A8 WO2010019279A8 PCT/US2009/033919 US2009033919W WO2010019279A8 WO 2010019279 A8 WO2010019279 A8 WO 2010019279A8 US 2009033919 W US2009033919 W US 2009033919W WO 2010019279 A8 WO2010019279 A8 WO 2010019279A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dosage form
- drug
- piece
- dosage
- administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09806994A EP2331080A4 (fr) | 2008-08-12 | 2009-02-12 | Compositions pharmaceutiques configurées pour dissuader le fractionnement des formes posologiques |
CA2734075A CA2734075C (fr) | 2008-08-12 | 2009-02-12 | Compositions pharmaceutiques configurees pour dissuader le fractionnement des formes posologiques |
AU2009282376A AU2009282376A1 (en) | 2008-08-12 | 2009-02-12 | Pharmaceutical compositions configured to deter dosage form splitting |
US13/058,757 US10314788B2 (en) | 2007-08-13 | 2009-02-12 | Pharmaceutical compositions configured to deter dosage form splitting |
US16/360,865 US20190209480A1 (en) | 2007-08-13 | 2019-03-21 | Pharmaceutical compositions configured to deter dosage form splitting |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
USPCT/US2008/072914 | 2008-08-12 | ||
USPCT/US2008/007291 | 2008-08-12 | ||
PCT/US2008/072914 WO2009023672A2 (fr) | 2007-08-13 | 2008-08-12 | Médicaments résistant aux abus, procédés d'utilisation et de fabrication |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/072914 Continuation-In-Part WO2009023672A2 (fr) | 2007-08-13 | 2008-08-12 | Médicaments résistant aux abus, procédés d'utilisation et de fabrication |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/058,757 A-371-Of-International US10314788B2 (en) | 2007-08-13 | 2009-02-12 | Pharmaceutical compositions configured to deter dosage form splitting |
US16/360,865 Continuation US20190209480A1 (en) | 2007-08-13 | 2019-03-21 | Pharmaceutical compositions configured to deter dosage form splitting |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010019279A1 WO2010019279A1 (fr) | 2010-02-18 |
WO2010019279A8 true WO2010019279A8 (fr) | 2011-03-17 |
Family
ID=41674715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/033919 WO2010019279A1 (fr) | 2007-08-13 | 2009-02-12 | Compositions pharmaceutiques configurées pour dissuader le fractionnement des formes posologiques |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2331080A4 (fr) |
AU (1) | AU2009282376A1 (fr) |
CA (1) | CA2734075C (fr) |
WO (1) | WO2010019279A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA94916C2 (ru) | 2005-09-09 | 2011-06-25 | Лабофарм Инк. | Композиция тразодона для введения один раз в день |
KR101458334B1 (ko) | 2010-12-23 | 2014-11-04 | 퍼듀 퍼머 엘피 | 탬퍼 저항성 고체 경구 투여 형태 |
US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050163843A1 (en) * | 2003-12-31 | 2005-07-28 | Garth Boehm | Alprazolam formulations |
TWI415635B (zh) * | 2004-05-28 | 2013-11-21 | 必治妥施貴寶公司 | 加衣錠片調製物及製備彼之方法 |
WO2007013975A2 (fr) * | 2005-07-20 | 2007-02-01 | Pharmorx Inc. | Compositions et procedes destines a controler l'abus de medicaments |
CN101801350A (zh) * | 2007-08-13 | 2010-08-11 | 阿巴斯迪特宁医药有限公司 | 抗滥用药物、使用方法和制备方法 |
-
2009
- 2009-02-12 AU AU2009282376A patent/AU2009282376A1/en not_active Abandoned
- 2009-02-12 EP EP09806994A patent/EP2331080A4/fr not_active Withdrawn
- 2009-02-12 WO PCT/US2009/033919 patent/WO2010019279A1/fr active Application Filing
- 2009-02-12 CA CA2734075A patent/CA2734075C/fr active Active
Also Published As
Publication number | Publication date |
---|---|
CA2734075A1 (fr) | 2010-02-18 |
EP2331080A4 (fr) | 2012-11-07 |
EP2331080A1 (fr) | 2011-06-15 |
WO2010019279A1 (fr) | 2010-02-18 |
AU2009282376A1 (en) | 2010-02-18 |
CA2734075C (fr) | 2017-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008019996A3 (fr) | Formulations de flibansérine et leur procédé de fabrication | |
WO2004069198A3 (fr) | Formes galeniques solides orales transmucosales exemptes de sucre et utilisations de celles-ci | |
WO2011160136A3 (fr) | Formes pharmaceutiques orales contenant de la progestérone et procédés associés | |
WO2008142572A3 (fr) | Formulation de comprimé à libération contrôlée contenant de l'aluminométasilicate de magnésium | |
WO2008146178A3 (fr) | Nouvelle forme posologique de comprimé | |
NO20070887L (no) | Kornformet farmasoytisk preparat med tidsbegrenset frigivelse for oral administrasjon, og intraoral hurtig desintegrerende tablett som inneholder preparatet | |
NZ600129A (en) | Capsule formation of pirfenidone and pharmaceutically acceptable excipients | |
WO2010103544A3 (fr) | Nouvelle composition à libération prolongée de composés choisis dans la classe des relaxants musculaires à action centrale | |
WO2013022783A3 (fr) | Formes de posologie orale contenant de la progestérone et procédés associés | |
WO2003013433A3 (fr) | Formulations d'antagoniste sequestre | |
WO2005039499A3 (fr) | Pellicules a desintegration rapide destinees a l'administration d'agents pharmaceutiques ou cosmetiques | |
WO2006089312A3 (fr) | Formulations orales de cci-779 biodisponibles | |
CO5170471A1 (es) | Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio | |
SG10201407947WA (en) | Compressible-coated pharmaceutical compositions and tablets and methods of manufacture | |
WO2007009806A3 (fr) | Formulations posologiques solides de medicaments narcotiques presentant une adsorption buccale amelioree | |
WO2004064815A8 (fr) | Formulation de dosage oral | |
WO2006050002A3 (fr) | Compositions destinees a l'administration controlee de composes pharmaceutiquement actifs | |
CA2642851A1 (fr) | Preparation de niacine a faibles bouffees vasomotrices | |
MX2010007281A (es) | Composiciones farmaceuticas de amlodipina y valsartan. | |
WO2008023016A3 (fr) | Formulations galéniques de composés organiques | |
WO2006060731A3 (fr) | Utilisation d'atazanavir afin d'ameliorer les proprietes pharmacocinetiques de medicaments metabolises par ugt1a1 | |
NZ597488A (en) | Pharmaceutical for oral delivery comprising mgbg and methods of treating disease | |
WO2002024203A3 (fr) | Formulation à administrer oralement à libération contrôlée | |
WO2006053089A3 (fr) | Methodes et formulations permettant de preparer des compositions pharmaceutiques contenant du bupropion | |
WO2008062475A3 (fr) | Compositions pharmaceutiques d'ursodiol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09806994 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2734075 Country of ref document: CA |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009282376 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009806994 Country of ref document: EP |
|
ENP | Entry into the national phase in: |
Ref document number: 2009282376 Country of ref document: AU Date of ref document: 20090212 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13058757 Country of ref document: US |